Key result
Review summarizes the epidemiology, pathophysiology, and treatment of functional MR and TR across all LVEF phenotypes.
Why the study?
Data on the management of functional mitral and tricuspid regurgitation across the various heart failure phenotypes defined by left ventricular ejection fraction are limited.
This review provides a comprehensive overview of functional mitral and tricuspid regurgitation across all heart failure phenotypes, highlighting the need for more data on management.
Answers are grounded in this paper and cite their sources.
Offers unified framework for functional valve disease across HF phenotypes; leaves open optimal management pending dedicated trials.
Functional mitral regurgitation (FMR) and tricuspid regurgitation (FTR) occur due to cardiac remodeling in the presence of structurally normal valve apparatus. Two main mechanisms are involved, distinguishing an atrial functional form (when annulus dilatation is predominant) and a ventricular form (when ventricular remodeling and dysfunction predominate). Both affect the prognosis of patients with heart failure (HF) across the entire spectrum of left ventricle ejection fraction (LVEF), including preserved (HFpEF), mildly reduced (HFmrEF), or reduced (HFrEF). Currently, data on the management of functional valve regurgitation in the various HF phenotypes are limited. This review summarizes the epidemiology, pathophysiology, and treatment of FMR and FTR within the different patterns of HF, as defined by LVEF.
No takes yet. Share an insight, caveat, or question.
Cammalleri et al. (2023) conducted a review in Heart failure with functional mitral and tricuspid regurgitation. This review summarizes the epidemiology, pathophysiology, and treatment of functional mitral and tricuspid regurgitation across the entire spectrum of heart failure phenotypes defined by LVEF.
Synapse has enriched 10 related papers. Consider them for comparative context: